相关实验视频
Updated: Jul 28, 2025
13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.7K
研究方案:慢性阻塞性肺病中的肺炎和吸入性皮质类固醇治疗模式 - 使用序列分析 (PICCS) 的队列研究
Allan Klitgaard1,2, Rikke Ibsen3, Ole Hilberg4,2
1Department of Internal Medicine, Lillebaelt Hospital, Vejle, Denmark alksorensen@health.sdu.dk.
BMJ open
|June 1, 2023
概括
吸入性皮质类固醇 (ICS) 减少COPD恶化,但增加肺炎的风险. 这项研究确定了与ICS用户肺炎风险增加相关的患者特征.
科学领域:
- 肺部医学 肺部医学
- 流行病学 流行病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 吸入性皮质类固醇 (ICS) 是慢性阻塞性肺病 (COPD) 的基石疗法,有效减少恶化.
- 然而,ICS的使用与肺炎的风险增加有关,这对患者安全造成了重大关注.
- 识别具有较高ICS相关肺炎风险的特定患者个人资料对于个性化治疗策略至关重要.
研究的目的:
- 在接受 COPD 吸入性皮质类固醇治疗的人群中,确定与肺炎风险增加相关的患者特征.
- 为临床决策提供有关COPD患者的ICS处方和监测的信息.
主要方法:
- 一项基于登记的全国性队列研究,利用丹麦2008-2018年的健康登记.
- 个人级别的数据链接使用唯一的个人识别号码.
- 在3年的随访期内,进行序列分析以探索肺炎发病率和ICS治疗模式的集群.
主要成果:
- 该部分将在研究完成后填写.
结论:
- 该部分将在研究完成后填写.
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
256
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
256
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
319
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
319
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
01:26Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K